5,6-MDO-DMT

Last updated
5,6-MDO-DMT
5,6-MDO-DMT.svg
Clinical data
Routes of
administration 		Smoking [1]
ATC code
  • None
Pharmacokinetic data
Onset of action Unknown [1]
Duration of action Unknown [1]
Identifiers
  • 2-(5H-[1,3]dioxolo[4,5-f]indol-7-yl)-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H16N2O2
Molar mass 232.283 g·mol−1
3D model (JSmol)
  • CN(C)CCC1=CNC2=CC3=C(C=C21)OCO3
  • InChI=1S/C13H16N2O2/c1-15(2)4-3-9-7-14-11-6-13-12(5-10(9)11)16-8-17-13/h5-7,14H,3-4,8H2,1-2H3
  • Key:QHEIGHVZMWJQHB-UHFFFAOYSA-N

5,6-MDO-DMT, or 5,6-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known chemical compound of the tryptamine family. [1] It is the 5,6-methylenedioxy derivative of dimethyltryptamine (DMT) and is an analogue of 5-MeO-DMT. [1] In his 1991 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose as greater than 5 mg smoked and the duration as unknown. [1] 5,6-MDO-DMT produced no effects whatsoever at a dose of 5 mg smoked. [1] Higher doses were not assessed. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MDO-DMT. [1] 5,6-MDO-DMT was first described in the scientific literature by Toni B. Kline and colleagues in 1982. [2]

Contents

See also

References

  1. 1 2 3 4 5 6 7 8 9 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  2. ↑ Kline TB, Benington F, Morin RD, Beaton JM (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". J Med Chem. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID   7120280.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.